McCullough, Lauren E. https://orcid.org/0000-0001-6723-9540
Collin, Lindsay J.
Conway, Kathleen
White, Alexandra J.
Cho, Yoon Hee
Shantakumar, Sumitra
Terry, Mary Beth
Teitelbaum, Susan L.
Neugut, Alfred I.
Santella, Regina M.
Chen, Jia
Gammon, Marilie D.
Funding for this research was provided by:
National Institutes of Health (R25CA057726)
NIH (UO1CA/ES66572, R01CA109753, 3R01CA109753-04S1, P30ES009089, Z99 ES99999)
Department of Defense (BC972772)
Article History
Received: 2 May 2019
Accepted: 2 September 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: Institutional Review Board approval was obtained by all participating institutions (Columbia University, University of North Carolina Chapel Hill, and Emory University).
: Not applicable.
: S. Shantakumar is employed at Glaxosmithkline and owns shares. A. Neugut serves as a consultant for Otsuka Pharmaceuticals, Pfizer, Eisai, Hospira, Teva, and United Biosource Corp, and is also a member of the medical advisory board of EHE Intl. No potential conflicts of interest were disclosed by the other authors.